Strategic Partnerships Active collaborations with state health departments (New York DOH), McKesson, OpGen, OSU Medical Center, and Teqqa point to a receptiveness of hospitals, distributors, and research institutions to ILÚM’s infectious disease management and antimicrobial stewardship solutions. This opens sales routes through public health programs, distribution partners, and academic medical centers.

Analytics Advantage Acquiring Teqqa and focusing on precision analytics for infectious disease management strengthens ILÚM’s value prop for data-driven stewardship and statewide surveillance. Sell to health systems and state agencies seeking genomic-informed antimicrobial resistance insights and performance dashboards.

Hospital Footprint The McKesson exclusive agreement to serve U.S. community hospitals and the OSU Medical Center collaboration demonstrate traction in the hospital market, suggesting primary targets are community hospitals, academic medical centers, and health systems needing sepsis and pneumonia management tools and stewardship support.

Tech Integration ILÚM’s web-centric tech stack indicates integration-friendly platforms and dashboard capabilities, enabling prospects to connect with existing EHRs and IT ecosystems. Opportunity to position services around system integrations with Epic, Cerner, and other HIS, plus customization and onboarding support.

Growth Pathways With a lean team and a path to scale through strategic partnerships within Merck’s Healthcare Services & Solutions network, public health programs, and distributor channels, ILÚM is positioned for co-sell arrangements, channel partnerships, and phased deployments to expand reach.